Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-06-18, Stock:ABBV, The news for the past five days is as follows:
2019-06-11: NEWS1: 10 Smart Dividend Stocks for the Rest of the Year.NEWS2: Roche's Polivy Gets FDA Nod, Gazyva Meets Goals in Phase II.NEWS3: Roche's Polivy Gets FDA Nod, Gazyva Meets Goals in Phase II.NEWS4: Roche's Polivy Gets FDA Nod, Gazyva Meets Goals in Phase II.NEWS5: Lilly Announces Tradjenta Cardiovascular Outcome Study Data.NEWS6: New Two-Year Data at the 24th World Congress of Dermatology Shows SKYRIZI™ (risankizumab) Maintains Complete Skin Clearance.NEWS7: AbbVie- Unique Mix of Growth, Income  Value.NEWS8: Horseman Capital Management’s Return, AUM, and Holdings.
2019-06-12: NEWS1: New Long-Term Data from Upadacitinib Phase 3 Studies in Rheumatoid Arthritis Including Results on Clinical Remission at 48 Weeks Presented at EULAR.NEWS2: 5 Most Valuable Pipeline Drugs in Development -- and the Stocks Poised to Profit.NEWS3: 10 Smart Dividend Stocks for the Rest of the Year.NEWS4: 10 Smart Dividend Stocks for the Rest of the Year.
2019-06-13: NEWS1: Amgen, Biogen, Gilead and Novo Nordisk have ‘very high’ capacity for M&A, says Moody’s.NEWS2: Pfizer's (PFE) Xeljanz Effective As Monotherapy in RA Study.NEWS3: Pfizer's (PFE) Xeljanz Effective As Monotherapy in RA Study.NEWS4: Pfizer's (PFE) Xeljanz Effective As Monotherapy in RA Study.
2019-06-14: NEWS1: 3 Big Pharma Stocks to Buy Right Now.
2019-06-17: NEWS1: J&J's (JNJ) Tremfya Meets Goal in Psoriatic Arthritis Study.NEWS2: J&J's (JNJ) Tremfya Meets Goal in Psoriatic Arthritis Study.NEWS3: AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know.NEWS4: Bayer to Invest 5 Billion Euros in Weedkiller Research.NEWS5: AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know.NEWS6: Novartis (NVS) Announces Promising Data on Tasigna & Hyrimoz.NEWS7: Novartis (NVS) Announces Promising Data on Tasigna & Hyrimoz.NEWS8: J&J's (JNJ) Tremfya Meets Goal in Psoriatic Arthritis Study.NEWS9: Novartis (NVS) Announces Promising Data on Tasigna & Hyrimoz.NEWS10: Top Ranked Income Stocks to Buy for June 17th.NEWS11: Notable ETF Inflow Detected - DGRO, VZ, ABBV, MRK.NEWS12: Notable ETF Inflow Detected - DGRO, VZ, ABBV, MRK.NEWS13: Top Ranked Income Stocks to Buy for June 17th.NEWS14: Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio.NEWS15: Why AbbVie Is a Retiree's Dream Stock.NEWS16: Why AbbVie Is a Retiree's Dream Stock.NEWS17: Why AbbVie Is a Retiree&apos;s Dream Stock.

Answer: Decrease